Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study

NCT02023788 is registered in ClinicalTrials.gov with Medipost Co Ltd. as lead sponsor.

NCT NCT02023788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02023788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study
Lead sponsor
Medipost Co Ltd.
Phase
Observational
Overall status
Completed
Start date
April 30, 2014
Completion date
October 31, 2016
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, premature birth of newborn, respiratory tract infections